Dr. Starling plays the invaluable role in supporting Merck’s work on political and federal advocacy issues by providing not only content expertise on Merck’s portfolio of products and development pipeline, but also helping ensure that the government affairs team is able to educate congressional staff on issues surrounding the innovation ecosystem and Merck’s commitment to research and development. His extensive experience gives him a unique ability to distill the science and rapidly assess the business implications of complex policy proposals focused on the biopharmaceutical industry.
Dr. Gary Starling
